Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Readyfusor vs ropivacaine infiltration for postoperative analgesia
CTR20210250Phase 3Terminated
- Sponsor
- Zhaoke Pharmaceutical (Hefei) Co., Ltd.
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ReadyfusOR in postoperative pain, sponsored by Zhaoke Pharmaceutical (Hefei) Co., Ltd.. Started Feb 2021; status: terminated.
02
Drugs
ReadyfusOR
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20210250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210250.